Plus Therapeutics presents trial data at cancer conferences
Tweet Send to a Friend
Plus Therapeutics Inc. (NASDAQ: PSTV) announced its participation in the 40th Society for Immunotherapy of Cancer Annual Meeting and Melanoma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


